Join
Live feed
·
PRReleasevia Quantisnow
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals

ByQuantisnow·Wall Street's wire, on your screen.
ARCT· Arcturus Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARCT (Arcturus Therapeutics Holdings Inc.) and more on Quantisnow.